Please fill in the form with your username, your password will be send to your registered e-mail.
* Mandatory fields
Website dedicated to help patients, their family and friends about the cancer immunotherapeutic approach in an easy-to-understand format.
Website providing information about the now recruiting Non-Small Cell Lung Cancer phase III clinical study
This section is devoted to present the potential advantages of the ASCI approach. ASCI is made of a tumor antigen, delivered as recombinant proteins and combined with potent immunological Adjuvant System.
If this is your first time at this site, please click here to register.
Register now
For legal reasons, this page is intended solely for healthcare professionals. This is why we ask you to register.
© 2001 - 2008 GlaxoSmithKline plc. All rights reserved.